Middle East and Africa Throat Cancer Diagnostics Market is expected to reach USD 99.13 million by 2030

Middle East and Africa throat cancer diagnostics market is expected to grow in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.8% in the forecast period of 2023 to 2030 and is expected to reach USD 99.13 million by 2030 from USD 62.97 million in 2022.

Increasing awareness about throat cancer has enhanced the market demand. The rising healthcare expenditure for better health services also contributes to the market's growth. The major market players focus on various service launches and approvals during this crucial period.

Read More Info:
https://www.databridgemarketresearch.com/reports/middle-east-and-africa-throat-cancer-diagnostics-market

Market Definition

Throat cancer is a type of cancer that forms in tissues of the pharynx (the hollow tube inside the neck that starts behind the nose and ends at the top of the windpipe and esophagus). Throat cancer includes cancer of the nasopharynx (the upper part of the throat behind the nose), the oropharynx (the middle part of the pharynx), and the hypopharynx (the bottom part of the pharynx). Cancer of the larynx (voice box) may also be included as a type of throat cancer. Most throat cancers are squamous cell carcinomas (cancer that begins in thin, flat cells that look like fish scales), also called pharyngeal cancer.

Recent Developments

In August 2022, F. Hoffmann-La Roche Ltd, announced the launch of the Digital LightCycler System, Roche's first digital polymerase chain reaction (PCR) system. This next-generation system detects disease and is designed to accurately quantify trace amounts of specific DNA and RNA targets not typically detectable by conventional PCR methods. This has helped the company to increase its Middle East and Africa presence in the market
In March 2021, Hologic, Inc. announced that the company had acquired Diagenode, a privately held Globalan developer and manufacturer of molecular diagnostic assays and epigenetics products. This further strengthens the molecular diagnostics business in the Middle East and Africa market

Some of the major players operating in the Middle East and Africa throat cancer diagnostics market are F. Hoffmann-La Roche Ltd., FUJIFILM Corporation, Thermo Fisher Scientific Inc., Koninklijke Philips N.V., Merck KGaA, BD, General Electric Company, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Abbott, QIAGEN, Siemens Healthcare GmbH, Quest Diagnostics Incorporated, Hologic, and PlexBio among others.

https://dbmrbuisness.blogspot.com/2023/06/in-vivo-imaging-market-is-expected-to.html

https://dbmrbuisness.blogspot.com/2023/06/global-capillary-blood-collection.html

https://dbmrbuisness.blogspot.com/2023/06/pulmonary-drug-delivery-market-will.html

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:-
Data Bridge Market research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

This release was published on openPR.